Cambridge scientists develop ‘super test’ for prostate cancer
17th February 2025 Uncategorised 0New test aims to revolutionise prostate cancer screening More: Cambridge scientists develop ‘super test’ for prostate cancer Source: News
read more
New test aims to revolutionise prostate cancer screening More: Cambridge scientists develop ‘super test’ for prostate cancer Source: News
read more
New funding to investigate cognitive decline and brain ageing More: Bath researchers awarded Wellcome grant for psychotic disorder study Source: News
read moreThe new FDA approval gives Daiichi Sankyo’s Turalio some company in a rare tumor type. More: FDA approves Ono's rare tumor drug from .4B Deciphera buyout Source: fierce
read moreThe company’s Penmenvy combines components of its established MenB and MenACWY vaccines Bexsero and Menveo, respectively. More: With new FDA approval, GSK joins Pfizer in the 5-in-1 meningococcal vaccine ring Source: fierce
read moreIn 2024’s fourth quarter, Moderna’s cost of sales came out to $739 million, which included a major $238 million charge tied to the cancellation of a contract manufacturing agreement toward the end of the year. More: Moderna shoulders 8M contract
read moreA group of former leaders from health comms giant Inizio Evoke have come together to launch Flex Marketing, a new agency catering to pharmaceutical, biotech, medtech and health tech clients. More: Inizio Evoke alums flex healthcare marketing prowess with launch
read more© 1994 - 2026 B.M. Pharmaceuticals